Joseph A. Tino - Concepedia

Author

Joseph A. Tino

Also Known As

J A Tino, J. A. TINO, J. TINO, J.A. Tino, Jeffrey A. Robl, Joseph A. Tino, Joseph Tino, Scott A. Biller, Tino, J.A., Tino, Joseph A.

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Biocon (India)Bristol-Myers Squibb (India)Bristol-Myers Squibb (Sweden)

About

Joseph A. Tino is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	25	1K
2	Biochemistry	13	17	788
3	Natural Sciences	12	13	392
4	Engineering	2	2	47
5	Health Sciences	1	1	268

Joseph A. Tino

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits John R. Wetterau, Richard E. Gregg, Thomas Harrity, Science HyperlipidemiaWhhl RabbitsMetabolic SyndromeMtp InhibitorsAtherosclerosis	1998	268
Discovery of 6-Fluoro-5-(<i>R</i>)-(3-(<i>S</i>)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)-2-methylphenyl)-2-(<i>S</i>)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1<i>H</i>-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton’s Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers Scott H. Watterson, George V. De Lucca, Qing Shi, Journal of Medicinal Chemistry	2016	142
Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton’s Tyrosine Kinase (BTK) Scott H. Watterson, Qingjie Liu, Myra Beaudoin Bertrand, Journal of Medicinal Chemistry Tyrosine KinaseImmunologyQuantitative PharmacologyBiological TherapyInnate Immunity	2019	104
2-Hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors James J. Li, Haixia Wang, Joseph A. Tino, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesAtp-citrate Lyase InhibitorsMedicine	2007	89
Enhanced Gastrointestinal Motility with Orally Active Ghrelin Receptor Agonists Soratree Charoenthongtrakul, Derek J. Giuliana, Kenneth Longo, Journal of Pharmacology and Experimental Therapeutics	2009	60
Synthesis and antiviral activity of novel isonucleoside analogs Joseph A. Tino, Junius M. Clark, Anjalie Field, Journal of Medicinal Chemistry	1993	57
Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care Kathleen M. Gillooly, Claudine Pulicicchio, Mark A. Pattoli, PLoS ONE Tyrosine KinaseImmunologyImmune RegulationExperimental ModelsBiological Therapy	2017	55
Small Molecule Reversible Inhibitors of Bruton’s Tyrosine Kinase (BTK): Structure–Activity Relationships Leading to the Identification of 7-(2-Hydroxypropan-2-yl)-4-[2-methyl-3-(4-oxo-3,4-dihydroquinazolin-3-yl)phenyl]-9<i>H</i>-carbazole-1-carboxamide (BMS-935177) George V. De Lucca, Qing Shi, Qingjie Liu, Journal of Medicinal Chemistry Tyrosine KinaseImmunologyPharmacotherapyChemical BiologyPharmaceutical Chemistry	2016	50
Synthesis of SQ-32,829, a new nucleoside antiviral agent G. A. JACOBS, Joseph A. Tino, Robert Zahler Tetrahedron Letters MedicineAntiviral Drug DevelopmentVirologyAntiviral DrugPharmacology	1989	47
Discovery of a Potent and Novel Motilin Agonist James J. Li, Hannguang J. Chao, Haixia Wang, Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryFunctional SelectivityNovel Motilin AgonistMedicine	2004	42

Page 1